Market research
603882.SHG Guangzhou Kingmed Diagnostics Group Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 12B
- P/E ratio
- 115.73
- Analyst target
- 31.1867
- Dividend yield
- 3.4%
- Beta
- 0.37
Community
Investor discussion
1 comment
Sign in to join the 603882.SHG discussion.
5 years, 5 months ago
Guangzhou Kingmed Diagnostics Group Co., Ltd is currently in a long term uptrend where the price is trading 7.1% above its 200 day moving average.
From a valuation standpoint, the stock is 9.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.7.
Guangzhou Kingmed Diagnostics Group Co., Ltd's total revenue rose by 70.8% to $2B since the same quarter in the previous year.
Its net income has increased by 238.7% to $499M since the same quarter in the previous year.
Finally, its free cash flow grew by 347.8% to $546M since the same quarter in the previous year.
Based on the above factors, Guangzhou Kingmed Diagnostics Group Co., Ltd gets an overall score of 5/5.